Certain high blood pressure medications may alter heart risk in people with HIV
(American Heart Association) Some blood pressure medications altered the likelihood of subsequent heart disease, stroke or heart failure in a study of veterans who have HIV (human immunodeficiency virus).Patients with HIV prescribed beta-blockers were more likely to develop cardiovascular disease compared to patients taking other blood pressure medications, even if their blood pressure was well controlled. All other classes of hypertensive medications showed no differences regarding cardiovascular risk outcomes. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 5, 2021 Category: International Medicine & Public Health Source Type: news
Janssen Announces U.S. FDA Approval of PONVORY ™ (ponesimod), an Oral Treatment for Adults with Relapsing Multiple Sclerosis Proven Superior to Aubagio® (teriflunomide) in Reducing Annual Relapses and Brain Lesions
TITUSVILLE, N.J. – (March 19, 2021) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) approved PONVORY™ (ponesimod), a once-daily oral selective sphingosine-1-phosphate receptor 1 (S1P1) modulator, to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease.1,2,3 PONVORY™ offers MS patients superior efficacy in reducing annualized relapse rates compared to an established oral therapy and a proven safety profile backed by ove...
Source: Johnson and Johnson - March 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
What You Don't Know About Beta-Blockers and Hemodialysis What You Don't Know About Beta-Blockers and Hemodialysis
A new look at the literature turned up a finding that surprised this nephrologist.Medscape Nephrology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 18, 2021 Category: Consumer Health News Tags: Nephrology Viewpoint Source Type: news
Beta Blockers Won ’ t Cause Depression, But Might Impair Sleep: Study
(Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - March 16, 2021 Category: Psychiatry Tags: Cardiology, Neurology, Psychiatry, News, Source Type: news
Beta Blockers Won't Cause Depression, But Might Impair Sleep: Study
TUESDAY, March 16, 2021 -- Millions of people take a beta blocker regularly, and a new study brings good news: The medications will not raise the risk of depression.
Beta blockers are used to treat conditions such as heart failure, chest pains,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 16, 2021 Category: General Medicine Source Type: news
Beta Blockers Won't Cause Depression, But Might Impair Sleep: Study
Title: Beta Blockers Won ' t Cause Depression, But Might Impair Sleep: StudyCategory: Health NewsCreated: 3/16/2021 12:00:00 AMLast Editorial Review: 3/16/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - March 16, 2021 Category: Cardiology Source Type: news
Beta blockers not associated with risk of depression
(Charit é - Universit ä tsmedizin Berlin) Drugs such as beta-adrenergic antagonists (beta blockers) have been linked to a range of adverse effects, including depression. But how reliable are these data, and which psychiatric side effects might indeed be caused by these drugs? These questions have been addressed by a team of researchers from Charit é - Universit ä tsmedizin Berlin, whose comprehensive meta-analysis has been published inHypertension*. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 15, 2021 Category: International Medicine & Public Health Source Type: news
Certain Antihypertensives Tied to Benefit After Aortic Dissection Certain Antihypertensives Tied to Benefit After Aortic Dissection
In a population-based cohort study, use of either beta blockers, ACE inhibitors, or ARBS was associated with benefits vs other such agents in the long-term treatment of patients with aortic dissection.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 10, 2021 Category: Consumer Health News Tags: Cardiology News Source Type: news
Is lactate lower in septic patients who are prescribed beta blockers? Retrospective cohort study of an intensive care population, Emergency Medicine Australasia 33(1): 82-87
Conclusions: In our cohort pre‐existing beta blocker treatment was associated with lower serum lactate measurements in patients presenting with sepsis. Pre‐existing beta blocker treatment may reduce serum lactate at presentatio n in patients with sepsis. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - March 3, 2021 Category: Consumer Health News Source Type: news
Beta-Blocker May Improve Melanoma Treatment Response Beta-Blocker May Improve Melanoma Treatment Response
Response rates were high without dose-limiting toxicities in a small phase 1 study that evaluated the addition of propranolol to pembrolizumab in treatment-naive patients with metastatic melanoma.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 10, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Cancer treatment could be replicated for COVID-19
Beta-blockers could potentially be used to treat COVID-19, according to a new international study by Italian and Australian scientists.
University of South Australia cancer researcher, Dr Nirmal Robinson, working with a team in Naples, has found evidence in animal models that the beta-blocker Propranolol helps suppress the spread of cancer in the lung which has an inflammatory profile very similar to COVID-19. (Source: World Pharma News)
Source: World Pharma News - November 3, 2020 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Cancer treatment could be replicated for COVID-19
(University of South Australia) Beta-blockers could potentially be used to treat COVID-19, according to a new international study by Italian and Australian scientists. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 2, 2020 Category: Cancer & Oncology Source Type: news
Consumer Health: Beta blockers and weight gain
Beta blockers are medications that reduce your blood pressure. They cause your heart to beat more slowly and with less force, which lowers blood pressure. Beta blockers also open up your veins and arteries to improve blood flow. Beta blockers are used to prevent, treat or improve symptoms in people who have irregular heart rhythm, [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 29, 2020 Category: Databases & Libraries Source Type: news
Breakthroughs in COPD From ERS 2020 Breakthroughs in COPD From ERS 2020
Highlights in COPD from the ERS 2020 virtual congress include therapy escalation and de-escalation, compliance with GOLD guidelines, and a potential reason for the beneficial effect of beta-blockers.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 29, 2020 Category: Consumer Health News Tags: None ReCAP Source Type: news
Breast cancer medication risk
(Flinders University) New research led by Flinders University has found a link between beta-blockers and survival outcomes in some breast cancer patients. Beta-blockers, commonly used to manage cardiovascular disease, were negatively associated with survival outcomes in patients with HER2 (Human Epidermal Growth Factor Receptor 2) positive advanced breast cancer, according to a new paper in the Frontiers In Oncology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 29, 2020 Category: Cancer & Oncology Source Type: news
